Evidence map›Paper›PMID 32207070›Full record

ReviewDrug delivery and translational research2020

3D printing for oral drug delivery: a new tool to customize drug delivery.

Manisha Pandey, Hira Choudhury, Joyce Lau Chui Fern, Alice Teo Kee Kee, Janice Kou, Jane Lee Jia Jing, How Chiu Her, Hong Sin Yong, Hon Chian Ming, Subrat Kumar Bhattamisra and 1 more

Abstract readReview
PubMed Publisher
In one paragraph

Review in Drug delivery and translational research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed, 1 pooled it
5.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 1 synthesis or guideline pooled it, 130 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Review
  13. Review
  14. Review
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Additive manufacturing in nano drug delivery systems.Pharmaceutical science advances · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Manisha PandeyDepartment of Pharmaceutical Technology, School of Pharmacy, International Medical University, Bukit Jalil, 57000, Kuala Lumpur, Malaysia. manisha.ukm@gmail.com.ORCID 0000-0002-8249-9743
Hira ChoudhuryDepartment of Pharmaceutical Technology, School of Pharmacy, International Medical University, Bukit Jalil, 57000, Kuala Lumpur, Malaysia.
Joyce Lau Chui FernSchool of Pharmacy, International Medical University, 57000, Kuala Lumpur, Malaysia.
Alice Teo Kee KeeSchool of Pharmacy, International Medical University, 57000, Kuala Lumpur, Malaysia.
Janice KouSchool of Pharmacy, International Medical University, 57000, Kuala Lumpur, Malaysia.
Jane Lee Jia JingSchool of Pharmacy, International Medical University, 57000, Kuala Lumpur, Malaysia.
How Chiu HerSchool of Pharmacy, International Medical University, 57000, Kuala Lumpur, Malaysia.
Hong Sin YongSchool of Pharmacy, International Medical University, 57000, Kuala Lumpur, Malaysia.
Hon Chian MingSchool of Pharmacy, International Medical University, 57000, Kuala Lumpur, Malaysia.
Subrat Kumar BhattamisraDepartment of Life Sciences, School of Pharmacy, International Medical University, Bukit Jalil, 57000, Kuala Lumpur, Malaysia.
Bapi GorainSchool of Pharmacy, Faculty of Health and Medical Sciences, Taylor's University, 47500, Subang Jaya, Selangor, Malaysia.
IMU University · MYTaylor's University · MY

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The involvement of recent technologies, such as nanotechnology and three-dimensional printing (3DP), in drug delivery has become the utmost importance for effective and safe delivery of potent therapeutics, and thus, recent advancement for oral drug delivery through 3DP technology has been expanded. The use of computer-aided design (CAD) in 3DP technology allows the manufacturing of drug formulation with the desired release rate and pattern. Currently, the most applicable 3DP technologies in the oral drug delivery system are inkjet printing method, fused deposition method, nozzle-based extrusion system, and stereolithographic 3DP. In 2015, the first 3D-printed tablet was approved by the US Food and Drug Administration (FDA), and since then, it has opened up more opportunities in the discovery of formulation for the development of an oral drug delivery system. 3DP allows the production of an oral drug delivery device that enables tailor-made formulation with customizable size, shape, and release rate. Despite the advantages offered by 3DP technology in the drug delivery system, there are challenges in terms of drug stability, safety as well as applicability in the clinical sector. Nonetheless, 3DP has immense potential in the development of drug delivery devices for future personalized medicine. This article will give the recent advancement along with the challenges of 3DP techniques for the development of oral drug delivery. Graphical abstract.

Indexed as

Drug Delivery SystemsPrinting, Three-DimensionalAdministration, OralAnimalsHumans3DP technologiesCustomize drug deliveryOral drug deliveryTabletsThree-dimensional printing

Identifiers

PMID32207070
OpenAlexW3012742449

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.